<DOC>
	<DOCNO>NCT01078883</DOCNO>
	<brief_summary>The purpose study investigate association respiratory muscle performance , functional capacity , dyspnea , anxiety/depression symptom , 1-year respiratory morbidity rate , 1-year mortality patient primary stage IIIb IV lung cancer .</brief_summary>
	<brief_title>Respiratory Muscle Performance Functional Capacity Primary Stage IIIb IV Lung Cancer</brief_title>
	<detailed_description>Background Purpose : Respiratory muscle function important sustaining level physical activity require daily life . The purpose study investigate association respiratory muscle performance , functional capacity , dyspnea , anxiety/depression symptom , 1-year respiratory morbidity rate , 1-year mortality patient primary stage IIIb IV lung cancer . Methods : A total 120 patient newly diagnose primary stage IIIb IV lung cancer recruit National Taiwan University Hospital . Demographic clinical signs/syndromes obtain chart . Pain dyspnea measure use visual analog scale . Respiratory muscle strength test measure maximal inspiratory expiratory pressure ( PImax PEmax , respectively ) . Spirometric variable , force expiratory volume one second ( FEV1 ) force vital capacity ( FVC ) measure . Functional capacity measure use Karnofsky performance status Simmonds functional assessment . Anxiety/depression symptom measure use Hospital Anxiety Depression Scale . One year respiratory complication morbidity 1-year mortality record prospective nature . Spearman 's Pearson correlation coefficient use test relationship respiratory muscle performance multiple variable . Univariate stepwise multiple regression analysis use identify factor associate respiratory muscle performance , functional capacity , one-year respiratory morbidity one-year mortality rate patient primary stage IIIb IV lung cancer . Clinical relevance : The prevalence lung cancer increase recent year . The attempt understand relation respiratory muscle performance , functional capacity associate clinical course shed light whether chest physical therapy intervention beneficial patient primary IIIb IV lung cancer .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>Clinical diagnosis stage IIIb/V lung cancer Normal cognition ( Mini Mental State Examination score than/equal 24 point ) Able finish test A clinical diagnosis affect respiratory muscle function functional activity performance ( e.g . acute pneumonia )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Lung cancer</keyword>
	<keyword>Respiratory muscle strength</keyword>
	<keyword>Dyspnea</keyword>
	<keyword>Functional capacity</keyword>
</DOC>